Clinical Trial Site

Berlin, New Jersey 08009

0 studies enrolling now · 3 studies all time

What they study most

High Cardiovascular Risk, Hypertension, Schizophrenia, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM — Stopped early
• Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment — Stopped early